Elections › Corporate Influence › GILEAD SCIENCES, INC.

🏛️ GILEAD SCIENCES, INC.

CORPORATE LOBBYING & ELECTION INFLUENCE PROFILE

$15.6M
Lobbying Spend
$0
Campaign Spending
76
Lobbyists
0
Races Influenced
67
LDA Filings
Lobbying Issue Areas
🏥 Healthcare & Pharma🏭 Trade & Manufacturing🤖 Tech & AI
Filing Quarters
first_quarterfourth_quartersecond_quarterthird_quarter
Specific Lobbying Issues
Issues related to regulation of prescription drugs and biologics
Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare and
General advocacy surrounding pharmaceuticals and drug development.
Education about access to HIV medicines Education about the 340(b) program.
H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022.
Where the Money Is Going
Race Campaign $ Candidate(s)
No race-level spending data linked yet.
Source: Senate LDA lobbying disclosures + FEC campaign finance data + USAspending.gov via Hammerhead Intelligence
Lobbying $ = annual reported federal lobbying expenditures (company-wide). Campaign $ = IE spending directed at candidates in specific races. Govt Contracts $ = federal awards from USAspending.gov.
Last updated: 2026-04-25